Professor of Medicine and Microbiology, Biochemistry, & Immunology and Senior Advisor for Global Health Equity
Morehouse School of Medicine, Atlanta, Georgia
Dr. Graham is an Immunologist, Virologist, and Clinical Trials Physician with an extensive background in basic and translational research applied to vaccine development. Founding member of the Vaccine Research Center (VRC) at NIH in 2000 and retired in 2021 while serving as the VRC Deputy Director. Best known for his research on RSV pathogenesis, structure-based vaccine design, and application of mRNA delivery technology. He was involved in the advanced evaluation of vaccines and monoclonal antibodies for HIV, Ebola, and Chikungunya, and developed novel vaccines for RSV, influenza, Zika, paramyxoviruses, and coronaviruses including the first COVID-19 vaccine and monoclonal antibody to enter clinical testing and that subsequently achieved Emergency Use Authorization and licensure.